Skip to main content
Top
Published in: Surgery Today 8/2023

15-02-2023 | Colorectal Cancer | Original Article

Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a multicenter study

Authors: Akimitsu Tanio, Hiroaki Saito, Kazushi Hara, Ken Sugezawa, Chihiro Uejima, Kyoichi Kihara, Shigeru Tatebe, Yasuro Kurisu, Shunsuke Shibata, Toshio Yamamoto, Hiroshi Nishie, Setsujo Shiota, Takuji Naka, Kenji Sugamura, Kuniyuki Katano, Manabu Yamamoto, Yoshiyuki Fujiwara

Published in: Surgery Today | Issue 8/2023

Login to get access

Abstract

Purpose

We determined the usefulness of the estimation of physiologic ability and surgical stress (E-PASS), initially reported as a predictive factor for postoperative morbidity and mortality, as a prognostic indicator in stage II colorectal cancer (CRC).

Methods

Overall, 739 patients who underwent proctocolectomy for CRC at Tottori University Hospital and affiliated hospitals and histologically diagnosed with stage II CRC were included in the current study.

Results

A receiver operating characteristic (ROC) analysis of the five-year recurrence-free survival indicated that the comprehensive risk score (CRS) of E-PASS predicted postoperative recurrence. A multivariate analysis revealed that the presence of preoperative perforation, T4, v ≥ 2, and CRSHigh (≥ 0.2267) were independent predictors of postoperative recurrence. Patients were assigned a score using these factors, as follows: the presence of perforation = 1, the absence of preoperative perforation = 0, T4 = 1, T3 = 0, v2/3 = 1, v0/1 = 0, CRSHigh = 1, and CRSLow = 0 (total score: 0–4). Accordingly, the respective 5-year relapse-free survival rates were 91.0%, 83.6%, 70.3%, and 52.0% among those with scores of 0, 1, 2, and both 3 and 4 (P < 0.001).

Conclusions

The CRS predicts postoperative recurrence in patients with stage II CRC.
Literature
1.
go back to reference Benson AB III, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:3408–19.CrossRef Benson AB III, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:3408–19.CrossRef
2.
go back to reference Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21:v70-7.CrossRefPubMed Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21:v70-7.CrossRefPubMed
3.
go back to reference Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633–41.CrossRefPubMed Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633–41.CrossRefPubMed
4.
go back to reference Inamoto S, Kawada K, Okamura R, Hida K, Sakai Y. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2019;34:1303–15.CrossRefPubMed Inamoto S, Kawada K, Okamura R, Hida K, Sakai Y. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2019;34:1303–15.CrossRefPubMed
5.
go back to reference Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36:995–1001.PubMed Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36:995–1001.PubMed
6.
go back to reference Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, et al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget. 2016;7:58543–52.CrossRefPubMedCentral Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, et al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget. 2016;7:58543–52.CrossRefPubMedCentral
7.
go back to reference Yamamoto M, Saito H, Uejima C, Tanio A, Tada Y, Matsunaga T, et al. Estimation of physiological ability and surgical stress score is a useful prognostic indicator for elderly patients with colorectal cancer. Dig Surg. 2020;37:145–53.CrossRefPubMed Yamamoto M, Saito H, Uejima C, Tanio A, Tada Y, Matsunaga T, et al. Estimation of physiological ability and surgical stress score is a useful prognostic indicator for elderly patients with colorectal cancer. Dig Surg. 2020;37:145–53.CrossRefPubMed
8.
go back to reference Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, et al. Evaluation of the estimation of physiologic ability and surgical stress score as a prognostic indicator for older patients with gastric cancer. Dig Surg. 2020;37:171–8.CrossRefPubMed Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, et al. Evaluation of the estimation of physiologic ability and surgical stress score as a prognostic indicator for older patients with gastric cancer. Dig Surg. 2020;37:171–8.CrossRefPubMed
9.
go back to reference Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. Tokyo, Japan: Kanehara & Co., Ltd; 2018. Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. Tokyo, Japan: Kanehara & Co., Ltd; 2018.
10.
go back to reference Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.PubMed Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.PubMed
11.
go back to reference Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (the E-PASS score) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today. 1999;29:219–25.CrossRefPubMed Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (the E-PASS score) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today. 1999;29:219–25.CrossRefPubMed
12.
go back to reference André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.CrossRef André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.CrossRef
13.
go back to reference Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465–71.CrossRefPubMed Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465–71.CrossRefPubMed
14.
go back to reference Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.CrossRefPubMed Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.CrossRefPubMed
15.
go back to reference Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, et al. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial. Eur J Cancer. 2018;96:54–63.CrossRefPubMed Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, et al. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial. Eur J Cancer. 2018;96:54–63.CrossRefPubMed
16.
go back to reference Miyatani K, Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, et al. Combined analysis of the pre- and postoperative neutrophil–lymphocyte ratio predicts the outcomes of patients with gastric cancer. Surg Today. 2018;48:300–7.CrossRefPubMed Miyatani K, Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, et al. Combined analysis of the pre- and postoperative neutrophil–lymphocyte ratio predicts the outcomes of patients with gastric cancer. Surg Today. 2018;48:300–7.CrossRefPubMed
17.
go back to reference Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Qin A, et al. Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer. Lung Cancer. 2022;163:35–41.CrossRefPubMed Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Qin A, et al. Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer. Lung Cancer. 2022;163:35–41.CrossRefPubMed
18.
go back to reference Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, et al. Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbecks Arch Surg. 2017;402:501–7.CrossRef Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, et al. Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbecks Arch Surg. 2017;402:501–7.CrossRef
19.
go back to reference Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37:2688–92.CrossRefPubMed Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37:2688–92.CrossRefPubMed
20.
go back to reference Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, et al. Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg. 2020;271:693–700.CrossRefPubMed Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, et al. Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg. 2020;271:693–700.CrossRefPubMed
21.
go back to reference Arai Y, Saito H, Ikeguchi M. Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T cells associated with dysfunction of cell-mediated immunity after colorectal cancer operation. Yonago acta med. 2012;55:1–9.PubMedPubMedCentral Arai Y, Saito H, Ikeguchi M. Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T cells associated with dysfunction of cell-mediated immunity after colorectal cancer operation. Yonago acta med. 2012;55:1–9.PubMedPubMedCentral
Metadata
Title
Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a multicenter study
Authors
Akimitsu Tanio
Hiroaki Saito
Kazushi Hara
Ken Sugezawa
Chihiro Uejima
Kyoichi Kihara
Shigeru Tatebe
Yasuro Kurisu
Shunsuke Shibata
Toshio Yamamoto
Hiroshi Nishie
Setsujo Shiota
Takuji Naka
Kenji Sugamura
Kuniyuki Katano
Manabu Yamamoto
Yoshiyuki Fujiwara
Publication date
15-02-2023
Publisher
Springer Nature Singapore
Published in
Surgery Today / Issue 8/2023
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02656-2

Other articles of this Issue 8/2023

Surgery Today 8/2023 Go to the issue